A new Lyme disease vaccine is seeking FDA approval. Pfizer and Valneva, a French specialty vaccine company, say a Lyme disease vaccine they are developing has reduced infections by around 70% in clinical trials compared to placebo shots. The new vaccine differs from most other vaccines, said Katel...